1.Analysis of gene mutation and risk factors of thrombosis in patients with bcr-abl negative myeloproliferative neoplasms
Hongfei WU ; Xinsheng XIE ; Liu LIU ; Shaoying HOU
Journal of Leukemia & Lymphoma 2017;26(8):461-464,471
Objective To explore the relationship between gene mutation of JAK2 V617F, JAK2 (exon12), CALR, MPL and clinical features of patients with bcr-abl negative myeloproliferative neoplasms (MPN), and to analyze the risk factors of thrombosis. Methods Clinical features and laboratory tests of 115 patients with bcr-abl negative MPN were analyzed retrospectively. 34 patients with thrombosis were treated as the observation group, and 81 patients without thrombosis were treated as the control group. Results Among 71 primary thrombocythemia cases, the white blood cell count (WBC) and hemoglobin level of JAK2 V617F positive group and CALR positive group was higher than that of 4 gene mutations in negative group (F= 5.835, P= 0.005; F= 3.405, P= 0.039). The incidence of splenomegaly in JAK2 V617F positive group and CALR positive group was higher than that of 4 gene mutations in negative group (χ2=16.902, P=0.0002; χ2= 12.658, P= 0.001). The patients'proportion of JAK2 V617F positive, high hemoglobin level (male ≥160 g/L, female ≥150 g/L), hypertension and over 60 years old in the observation group was higher than that in the control group (χ2= 5.585, P= 0.025; χ2= 4.909, P= 0.043; χ2= 8.891, P= 0.004; χ2=15.933, P=0.023). Conclusion The detection of JAK2 V617F, JAK2 (exon12), CALR and MPL gene mutations is helpful to the diagnosis of bcr-abl negative MPN; JAK2 V617F positive, high hemoglobin level, hypertension, and elderly age are risk factors of thrombosis.
2.Microvascular decompression in treating cranial nerve diseases
Zhiqiang ZHANG ; Tao HUANG ; Xiaochuan LUO ; Caijun XIE ; Shaoying XIE ; Youbi SHEN ; Lisen SUI ; Fu HAN
Clinical Medicine of China 2008;24(9):926-928
Objective To study the efficacy of microvascular decompression in treating cranial nerve diseases. Methods 156 patients were treated with microvaseular decompression,of whom 119 were with trigeminal neuralgia,34 with hemifacial spasm and three with glossopharyngeal neuralgia.Rusults The overall effective rate was 96.8%(151/156) and the corresponding effective rate for the above three conditions were 94.2%,97.1% and 66.7%. Conlusions Mierovaseular decompression iS an effective treatment for cranial nerve diseases.
3.Efficacy of haploidentical allogeneic hematopoietic stem cell transplantation for severe aplastic anemia: a report of 40 cases
Hongfei WU ; Xinsheng XIE ; Dingming WAN ; Rong GUO ; Chong WANG ; Ling SUN ; Hui SUN ; Zhongxing JIANG ; Shaoying HOU
Chinese Journal of Organ Transplantation 2019;40(3):153-157
Objective To explore the efficacy and prognosis of haploidentical allogeneic hematopoietic stem cell transplantation (haplo-HSCT) for severe aplastic anemia (SAA).Methods The clinical data were retrospectively analyzed for 40 SAA cases undergoing haplo-HSCT from September 2013 to February 2018.The conditioning regimen contained cyclophosphamide,fludarabine and antithymocyte globulin with or without busulfan or low-dose total body irradiation.Cyclosporin A,short-term methotrexate and mycophenolate mofetil were dosed for preventing graft versus host disease (GVHD).The median counts of mononuclear cell and CD34+ stem cell were 5.3(2.0~13.5) × 108/kg and 5.6 (1.6 ~ 15.9) × 106/kg respectively.Results Among them,hematopoietic reconstitution was achieved (n =36,90.0 %).The median times for myeloid engraftment and platelet engraftment were 15(10-25) and 17(10~58) days respectively.The incidence of acute graft-versushost disease(aGVHD)was (35.0± 6.8) %.The incidence of chronic GVHD (cGVHD) was (23.0 ±7.4) %.And 28 SAA cases (70.0 %) survived during a median follow-up period of 353(30~1226)days,The cumulative overall survival (OS) was (67.8 ± 7.8) %,the average survival time (883 ± 82)days and transplantation-related death (TRM) within 100 days (10.0 ± 3.1) %.Conclusions Haplo-HSCT is an effective treatment for SAA patients.And a larger number of cases are required for enhancing OS.
5.Laboratory detection on severe acute respiratory syndrome
Jicheng HUANG ; Zhuoyue WAN ; Qiuxia CHEN ; Hui LI ; Kui ZHENG ; Huanying ZHENG ; Xinge YAN ; Xin ZHANG ; Ling FAN ; Jie LI ; Xiaoling DENG ; Huiqiong ZHOU ; Ping HUANG ; Limei DIAO ; Haojie ZHONG ; Wanli ZHANG ; Shaoying XIE ; Jingdiao CHENG ; Jian WANG ; Jinyan LIN ; Feng DENG
Chinese Journal of Laboratory Medicine 2003;0(10):-
Objective To provide scientific evidence to identify and confirm severe acute respiratory syndrome (SARS) by laboratory detection.Methods Multiple clinical specimens were collected serially and systematically from the 4 suspected SARS patients, which occurred between Dec.2003 to Jan.2004 in Guangdong Province. The samples were tested by serologic and molecular methods.Results IgM or IgG antibodies against SARS-CoV were detectable after 6—8 days of the onset in four patients. The four-fold or greater rising in antibodies was clearly detected in three of the four patients, while the fourth patient’s seroconversion was from negative to positive. The results analysed by enzyme-linked immunosorbent assay( ELISA), immunoflourescence assay (IFA), and neutralization test were highly correlated. SARS-CoV RNA was just detected in 3 throat swab specimens from case 1 by real-time PCR. M, N and S genes were amplified by reverse transcriptase polymerase chain reaction (RT-PCR) from the positive samples. Sequencing results showed that they were SARS-CoV gene segments, and most closely matched SARS-CoV gene sequences were isolated from civet cats in Guangdong Province. Nevertheless, SARS-CoV was not isolated from any samples of the 4 patients.Conclusion Based on these results, the 4 reported cases were laboratorily confirmed as SARS cases.